A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.
Xu Z, Xu B, Lundström SL, Moreno-Giró À, Zhao D, Martin M, Lönnblom E, Li Q, Krämer A, Ge C, Cheng L, Liang B, Tong D, Stawikowska R, Blom AM, Fields GB, Zubarev RA, Holmdahl R.
Xu Z, et al. Among authors: lundstrom sl.
Nat Commun. 2023 Sep 23;14(1):5949. doi: 10.1038/s41467-023-41561-7.
Nat Commun. 2023.
PMID: 37741824
Free PMC article.